Skip to main content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Reported Impact of Discarded-Drug Refunds on Biosimilar Drugs

Section 90004 of the Infrastructure Investment and Jobs Act (the Act) requires manufacturers of certain single-dose containers or single-use package drugs, including biosimilar biologic products, payable under Medicare Part B to provide a refund for the discarded amounts of such drugs. In addition, section 90004 of the Act requires OIG, after consultation with CMS and the Food and Drug Administration, to submit a report to Congress on any reported impact that section 90004 may have on the licensure, market entry, market retention, or marketing of biosimilar biologic products. As such, we will determine the reported impact of discarded-drug refunds on licensure, market entry, market retention, or marketing of biosimilar drugs and submit a report to Congress.

Announced or Revised Agency Title Component Report Number(s) Expected Issue Date (FY)
Completed Centers for Medicare and Medicaid Services Reported Impact of Discarded-Drug Refunds on Biosimilar Drugs Office of Audit Services WA-23-0005 (W-00-23-35894);
A-06-23-04003		 2024